ArticleScientific reports2026
Factors associated with uptake of optimal dose of IPTP-SP among pregnant women attending antenatal clinics of Soroti district, Uganda.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Knowledge, attitudes, practices, and future intentions to use intermittent preventive treatment with sulfadoxine-pyrimethamine among pregnant women in southern Ghana.BMC pregnancy and childbirth · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malaria in pregnancy is a major Public Health problem globally especially in low- and middle-income countries, because it contributes significantly to maternal, foetal, and perinatal morbidity and mortality. Uptake of up to three doses (optimal dose) of intermittent preventive treatment using sulfadoxine pyrimethamine (IPTp-SP) has been shown to prevent malaria in pregnancy and placental malaria. We aimed to determine the factors associated with the uptake of optimal dose of IPTp-SP among pregnant women attending antenatal care in Soroti District. A cross-sectional study was conducted at selected health facilities in Soroti District between March and June 2023. Three hundred and forty-three pregnant women at 36 weeks gestation or more were enrolled into the study. Sociodemographic, obstetric, knowledge on malaria and health care service delivery factors were collected from the women to determine the factors associated with uptake of optimal dose of IPTpSP. Uptake of optimal dose of IPTp-SP was 86.6%. Factors associated with uptake of optimal dose of IPTp-SP were: knowledge about dangers of malaria in pregnancy (aOR: 2.42, 95%CI: 1.19–4.91), knowledge about IPTp-SP benefits (aOR: 4.15, 95%CI: 2.10–8.23) and having enough clean cups at the ANC clinic to facilitate directly observed therapy (DOT) (aOR 5.43, 95% CI: 2.44–12.1). Uptake of optimal dose of IPTp-SP was high. Knowledge about dangers of malaria in pregnancy, IPTp-SP benefits and, always having enough clean cups at the ANC to implement DOT were associated with optimal IPTp-SP uptake. There is need to increase awareness among pregnant women and facilitate Directly Observed Therapy in antenatal clinics as these will improve IPTp-SP uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.